e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
New biomarkers for management of obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low blood eosinophil count is associated with gram-positive cocci infection and poor clinical outcomes in severe exacerbations of COPD
F. Wang (Beijing, China), L. Yang (Beijing, China), M. Wang (Beijing, China), B. He (Beijing, China)
Source:
Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Session:
New biomarkers for management of obstructive diseases
Session type:
Oral Presentation
Number:
4719
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Wang (Beijing, China), L. Yang (Beijing, China), M. Wang (Beijing, China), B. He (Beijing, China). Low blood eosinophil count is associated with gram-positive cocci infection and poor clinical outcomes in severe exacerbations of COPD. 4719
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Blood eosinophil count predicts severity of respiratory failure, death and future exacerbations in severe life-threatening asthma
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD
Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018
Year: 2018
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
The relation of sputum color to bacterial load in exacerbations of COPD
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
High prevalence of gramnegative enteric bacilli and pseudomonas in mild exacerbation of early stages COPD (Gold I-II)
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017
Year: 2017
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept